U.S. flag

An official website of the United States government

NM_002768.5(CHMP1A):c.570-1G>C AND not specified

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Dec 23, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001806820.1

Allele description [Variation Report for NM_002768.5(CHMP1A):c.570-1G>C]

NM_002768.5(CHMP1A):c.570-1G>C

Gene:
CHMP1A:charged multivesicular body protein 1A [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
16q24.3
Genomic location:
Preferred name:
NM_002768.5(CHMP1A):c.570-1G>C
HGVS:
  • NC_000016.10:g.89646088C>G
  • NG_033005.2:g.16698G>C
  • NM_001083314.4:c.550-1G>C
  • NM_002768.5:c.570-1G>CMANE SELECT
  • NC_000016.9:g.89712496C>G
  • NM_002768.4:c.570-1G>C
Links:
dbSNP: rs2059771358
NCBI 1000 Genomes Browser:
rs2059771358
Molecular consequence:
  • NM_001083314.4:c.550-1G>C - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_002768.5:c.570-1G>C - splice acceptor variant - [Sequence Ontology: SO:0001574]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002051345Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Dec 23, 2021)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV002051345.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Variant summary: CHMP1A c.570-1G>C alters a conserved nucleotide located in a canonical splice-site of the last intron (intron 6) adjacent to the last coding exon 7 of the CHMP1A gene. It is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. Several computational tools predict a significant impact on normal splicing: Four predict the variant abolishes the canonical 3' splice acceptor site while four also predict the variant abolishes a hyopthetical 5' splice donor site of unknown significance. However, these predictions have yet to be confirmed by functional studies. The variant was absent in 193188 control chromosomes. To our knowledge, no occurrence of c.570-1G>C in individuals affected with Pontocerebellar Hypoplasia, Type 8 and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Dec 24, 2023